CVRX supply chain intelligence for CVRx, Inc.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.
Data compiled by Redley Lamar · ChainSifter Intelligence
CVRx, Inc. (CVRX) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| JEFFERIES-LLC | JEFFERIES-LLC | 92% | Pursuant to the terms of the Sale Agreement, the Company may offer and sell shares of the Company’s common stock, $0.01 par value per share (the “Shares”), having an aggregate offering amount of up t… |
| PIPER-SANDLER-CO | PIPER-SANDLER-CO | 90% | On November 4, 2022, we entered into an Equity Distribution Agreement with Piper Sandler & Co., as agent, under which we may offer and sell, from time to time at our sole discretion, shares of our co… |
| ABT | Abbott Laboratories | 72% | Reciprocal relationship from ABT graph: Reciprocal relationship from CVRX graph: al device companies that have substantially greater financial, technical, sales and marketing resources than we do, su… |
| ABT | Abbott Laboratories | 72% | al device companies that have substantially greater financial, technical, sales and marketing resources than we do, such as Medtronic plc, Boston Scientific Corporation, Abbott Laboratories and Johns… |
| BSX | Boston Scientific Corporation | 72% | Reciprocal relationship from BSX graph: Reciprocal relationship from CVRX graph: al device companies that have substantially greater financial, technical, sales and marketing resources than we do, su… |
| BSX | Boston Scientific Corporation | 72% | al device companies that have substantially greater financial, technical, sales and marketing resources than we do, such as Medtronic plc, Boston Scientific Corporation, Abbott Laboratories and Johns… |
| JNJ | Johnson & Johnson | 72% | al device companies that have substantially greater financial, technical, sales and marketing resources than we do, such as Medtronic plc, Boston Scientific Corporation, Abbott Laboratories and Johns… |
| JNJ | Johnson & Johnson | 72% | Reciprocal relationship from JNJ graph: Reciprocal relationship from CVRX graph: al device companies that have substantially greater financial, technical, sales and marketing resources than we do, su… |
| MDT | Medtronic plc | 72% | al device companies that have substantially greater financial, technical, sales and marketing resources than we do, such as Medtronic plc, Boston Scientific Corporation, Abbott Laboratories and Johns… |
| MDT | Medtronic plc | 72% | Reciprocal relationship from MDT graph: Reciprocal relationship from CVRX graph: al device companies that have substantially greater financial, technical, sales and marketing resources than we do, su… |
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| ABT | Abbott Laboratories | 72% | Reciprocal relationship from ABT graph: Reciprocal relationship from CVRX graph: Reciprocal relationship from ABT graph: Reciprocal relationship from CVRX graph: Reciprocal relationship from ABT grap… |
| ABT | Abbott Laboratories | 72% | al device companies that have substantially greater financial, technical, sales and marketing resources than we do, such as Medtronic plc, Boston Scientific Corporation, Abbott Laboratories and Johns… |
| BSX | Boston Scientific Corporation | 72% | al device companies that have substantially greater financial, technical, sales and marketing resources than we do, such as Medtronic plc, Boston Scientific Corporation, Abbott Laboratories and Johns… |
| BSX | Boston Scientific Corporation | 72% | Reciprocal relationship from BSX graph: Reciprocal relationship from CVRX graph: Reciprocal relationship from BSX graph: Reciprocal relationship from CVRX graph: Reciprocal relationship from BSX grap… |
| JNJ | Johnson & Johnson | 72% | al device companies that have substantially greater financial, technical, sales and marketing resources than we do, such as Medtronic plc, Boston Scientific Corporation, Abbott Laboratories and Johns… |
| JNJ | Johnson & Johnson | 72% | Reciprocal relationship from JNJ graph: Reciprocal relationship from CVRX graph: al device companies that have substantially greater financial, technical, sales and marketing resources than we do, su… |
| MDT | Medtronic plc | 72% | Reciprocal relationship from MDT graph: Reciprocal relationship from CVRX graph: Reciprocal relationship from MDT graph: Reciprocal relationship from CVRX graph: Reciprocal relationship from MDT grap… |
| MDT | Medtronic plc | 72% | al device companies that have substantially greater financial, technical, sales and marketing resources than we do, such as Medtronic plc, Boston Scientific Corporation, Abbott Laboratories and Johns… |
| Instrument | Description | Confidence | Evidence |
|---|---|---|---|
| CVRX-DEBT-8960 | Xbrl Convertible | 90% | xbrl convertible detail from xbrl 2021-12-31. |
| CVRX-DEBT-8959 | Warrants outstanding: 12.66 | 90% | xbrl warrant detail from xbrl 2026-03-31. |
| CVRX-DEBT | Debt stack $61.9M | 90% | Market cache reports total debt of $61.9M. |
| Holder | Name | Confidence | Evidence |
|---|---|---|---|
| CVRX-OWNER-JOHNSON-JOHNSON | JOHNSON & JOHNSON | 90% | 13F overlay lists JOHNSON & JOHNSON as top holder; 92 tracked holders. |
| Ticker | Name | Chain Index | Hops | Relationship Types |
|---|---|---|---|---|
| BCAX | Bicara Therapeutics Inc. | 100.00 | 2 | |
| AURA | Aura Biosciences, Inc. | 100.00 | 2 | |
| ATRA | Atara Biotherapeutics, Inc. | 100.00 | 2 | |
| CLGN | CollPlant Biotechnologies Ltd. | 100.00 | 2 | |
| ABBV | AbbVie Inc. | 100.00 | 2 | |
| ACIU | AC Immune SA | 100.00 | 2 | |
| SNNUF | Smith & Nephew plc | 100.00 | 2 | |
| ALC | Alcon Inc. | 100.00 | 2 | |
| BSX | Boston Scientific Corporation | 100.00 | 1 | ['customer', 'supplier'] |
| CYTOF | Altamira Therapeutics Ltd. | 100.00 | 2 | |
| ANIK | Anika Therapeutics, Inc. | 100.00 | 2 | |
| ADGM | Adagio Medical Holdings, Inc. | 100.00 | 2 | |
| BLLN | BillionToOne, Inc. | 100.00 | 2 | |
| ABT | Abbott Laboratories | 100.00 | 1 | ['customer', 'supplier'] |
| CSTE | Caesarstone Ltd. | 100.00 | 2 | |
| BNR | Burning Rock Biotech Limited | 100.00 | 2 | |
| AORT | Artivion, Inc. | 100.00 | 2 | |
| BNRG | Brenmiller Energy Ltd | 100.00 | 2 | |
| AVBP | ArriVent BioPharma, Inc. | 100.00 | 2 | |
| ATON | AlphaTON Capital Corp | 100.00 | 2 |